Literature DB >> 29525818

Trends in Use and Expenditures of Brand-name Atorvastatin After Introduction of Generic Atorvastatin.

Haider J Warraich1, Joseph A Salami2, Rohan Khera3, Javier Valero-Elizondo2, Victor Okunrintemi2, Khurram Nasir4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29525818      PMCID： PMC5885171          DOI： 10.1001/jamainternmed.2018.0990

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  4 in total

1.  Estimation of Potential Savings Through Therapeutic Substitution.

Authors:  Michael E Johansen; Caroline Richardson
Journal:  JAMA Intern Med       Date:  2016-06-01       Impact factor: 21.873

2.  Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015.

Authors:  Alexander C Egilman; Joshua D Wallach; Joseph S Ross; Sanket S Dhruva
Journal:  JAMA Intern Med       Date:  2018-04-01       Impact factor: 21.873

3.  National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.

Authors:  Joseph A Salami; Haider Warraich; Javier Valero-Elizondo; Erica S Spatz; Nihar R Desai; Jamal S Rana; Salim S Virani; Ron Blankstein; Amit Khera; Michael J Blaha; Roger S Blumenthal; Donald Lloyd-Jones; Khurram Nasir
Journal:  JAMA Cardiol       Date:  2017-01-01       Impact factor: 14.676

4.  Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.

Authors:  Jing Luo; John D Seeger; Macarius Donneyong; Joshua J Gagne; Jerry Avorn; Aaron S Kesselheim
Journal:  JAMA Intern Med       Date:  2016-09-01       Impact factor: 21.873
  4 in total
  7 in total

1.  Generic Drugs in the United States: Policies to Address Pricing and Competition.

Authors:  Ravi Gupta; Nilay D Shah; Joseph S Ross
Journal:  Clin Pharmacol Ther       Date:  2019-01-10       Impact factor: 6.875

Review 2.  Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management?

Authors:  Khalid Mehmood; Afrasim Moin; Talib Hussain; Syed Mohd Danish Rizvi; D V Gowda; Shazi Shakil; M A Kamal
Journal:  Folia Microbiol (Praha)       Date:  2021-10-26       Impact factor: 2.099

3.  Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.

Authors:  Tianna Zhou; Patrick Liu; Sanket S Dhruva; Nilay D Shah; Reshma Ramachandran; Karina M Berg; Joseph S Ross
Journal:  JAMA Intern Med       Date:  2022-02-01       Impact factor: 44.409

4.  Ophthalmic Medication Expenditures and Out-of-Pocket Spending: An Analysis of United States Prescriptions from 2007 through 2016.

Authors:  Evan M Chen; Ninani Kombo; Christopher C Teng; Prithvi Mruthyunjaya; Kristen Nwanyanwu; Ravi Parikh
Journal:  Ophthalmology       Date:  2020-04-28       Impact factor: 14.277

5.  Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018.

Authors:  Shuo-Yu Lin; Kyle Baumann; Chenxuan Zhou; Weiyu Zhou; Alison Evans Cuellar; Hong Xue
Journal:  JAMA Netw Open       Date:  2021-11-01

6.  Public knowledge, perception, and experience with generic medications in Saudi Arabia.

Authors:  Omar A Almohammed; Leen A Aldwihi; Abdullah A Alhifany
Journal:  Saudi Med J       Date:  2020-04       Impact factor: 1.484

7.  Health informatics interventions to minimize out-of-pocket medication costs for patients: what providers want.

Authors:  Karalyn A Kiessling; Bradley E Iott; Jessica A Pater; Tammy R Toscos; Shauna R Wagner; Laura M Gottlieb; Tiffany C Veinot
Journal:  JAMIA Open       Date:  2022-02-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.